CONTRAVIR PHARMACEUTICALS IN's ticker is CTRVXXXX and the CUSIP is 21234W103.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $22,000 | +266.7% | 18,000 | +230.1% | 0.00% | – |
| Q3 2016 | $6,000 | 0.0% | 5,453 | 0.0% | 0.00% | – |
| Q2 2016 | $6,000 | -14.3% | 5,453 | 0.0% | 0.00% | – |
| Q1 2016 | $7,000 | -12.5% | 5,453 | 0.0% | 0.00% | – |
| Q4 2015 | $8,000 | -27.3% | 5,453 | 0.0% | 0.00% | – |
| Q3 2015 | $11,000 | -42.1% | 5,453 | +42.7% | 0.00% | – |
| Q2 2015 | $19,000 | – | 3,821 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Anson Funds Management LP | 1,132,737 | $1,399,000 | 0.21% |
| Prospera Financial Services Inc | 177,550 | $215,000 | 0.05% |
| LBA Wealth Management, LLC | 12,000 | $15,000 | 0.01% |
| Cambridge Investment Research Advisors, Inc. | 23,457 | $28,000 | 0.00% |
| TIAA CREF INVESTMENT MANAGEMENT LLC | 313,801 | $866,000 | 0.00% |
| TEACHERS ADVISORS, LLC | 148,551 | $410,000 | 0.00% |
| Balentine LLC | 55 | $0 | 0.00% |
| Capital Advisors, Ltd. LLC | 177 | $0 | 0.00% |
| Vantage Investment Advisors, LLC | 1,150 | $1,000 | 0.00% |
| BLACKROCK ADVISORS LLC | 5,453 | $7,000 | 0.00% |